In a significant move for the UK's life sciences sector, BioNTech, renowned for its role in developing the Pfizer-BioNTech COVID-19 vaccine, has announced a £1 billion investment over the next decade.  

The judgment considered a wide range of important issues including the continued use of the Waldram method to assess interference with light and the interaction with section 203 of the Housing and Planning Act 2016.

Subject access requests (SARs) continue to pose significant challenges for independent schools. They are often time-consuming, resource-intensive, and frequently linked to wider complaints or disputes. Here are some practical tips to help your school manage SARs effectively.

Tribunal free to hear claims from administrative staff where duties are not close to sovereign functions.

It's been a challenging few weeks for the UK life sciences sector. Following the breakdown of the talks with the Government to provide a more competitive reimbursement scheme for pharma, there have been a number of high-profile decisions that have created big concerns for the future of the sector. However, there have been some good news stories too, including a resilient message from MedCity - the life sciences arm of London and Partners, with whom VWV is a partner.

The EAT overturned a ruling that a nurse was both an employee and a worker, highlighting gaps on substitution and mutuality.